Work

417P SNC115 in patients with relapsed/refractory small cell lung cancer (SCLC) and large cell neuroendocrine carcinoma (LCNEC): Safety, pharmacokinetic, and preliminary efficacy results from a phase I study

Year: 2026

Type: article

Source: ESMO Open

DOI: 10.1016/j.esmoop.2026.106731

Authors: T. Chu, J. Qian, C. Shi, Y. Dong, Z. Gao, L. Xiong, Y. Zhou, J. Teng, H. Lu, Y. Kuang, R. Zhong, H. Zhong, Z. Yu, M. Xiong, Z. Xu, L. Wen, Z. Cao

Institutions: Shanghai Jiao Tong University, Shanghai Chest Hospital

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,910

Funders: Harbin Medical University, Chinese Academy of Sciences, Kunming Medical University, Jiangnan University, Tongji University, Zhengzhou University, Nanchang University, Zhejiang University, Sichuan University, Chinese Academy of Medical Sciences, University of Electronic Science and Technology of China, University of Chinese Academy of Sciences, West China Hospital, Sichuan University

OpenAlex ID: W7137828474

FWCI:

Cites:

Cited by:

Related to: